United States - Ekhbary News Agency
A groundbreaking study by the National Institutes of Health (NIH) has shed new light on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), a severe multisystem disorder often triggered by infection. Published in Nature Communications, the research identified significant differences in the immune and nervous systems of ME/CFS patients, providing long-awaited physiological evidence for a condition often dismissed as psychosomatic. This comprehensive investigation focused on a carefully selected cohort, revealing that killer T cells—critical components of the immune response—exhibit markers of "exhaustion," indicating a compromised ability to combat persistent triggers.
Read Also
→ Video Captures Deadly Cafe Explosion Moment in Russia→ Israeli Military: 'Thousands of Targets' Await Bombing in Iran as War Escalates→ Ukraine Demands Israel Seize Ship Carrying Alleged 'Stolen Grain'The study observed reduced levels of CD226 and elevated PD1 protein in killer T cells from ME/CFS participants, suggesting the immune system effectively burns out and struggles to respond effectively. These findings are particularly pertinent given the parallels drawn between ME/CFS and Long COVID, highlighting the urgent need for better diagnostics and therapies. Experts speculate that lingering infection remnants or factors like a "leaky gut" could contribute to this immune exhaustion. This research marks a pivotal step towards validating the physiological basis of ME/CFS and fostering a deeper understanding of its complex mechanisms, offering hope for future treatments.
